CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients [Phase 2]
Summary
Phase 2 clinical trial update investigating risk of hypoglycemia with sitagliptin in type 2 diabetes patients; results completed and posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Pharmacological Action | Phase 2 | Status: COMPLETED | Results posted: 2021-02-21